文献速递神经创伤神经重症

新冠疫情早期密歇根创伤质量改进计划数据库中创伤性脑损伤模式的变化

Changes in patterns of traumatic brain injury in the Michigan Trauma Quality Improvement Program database early in the COVID-19 pandemic.
PubMed 文献 · J Neurosurg · 2022-07-26

基于密歇根创伤质量改进计划(MTQIP)数据库36家一级和二级创伤中心数据,比较2020年3月13日至7月2日(新冠期)与2017-2019年同期(新冠前期)创伤性脑损伤(TBI)就诊率、患者特征、损伤严重程度和结局。新冠期前8周TBI就诊率下降18%,后8周上升16%,累计无差异;新冠期TBI患者受伤超过1天就诊比例更高(p=0.046),压疮率从1.0%升至2.1%(p=0.002),出院状态分布改变(p=0.01),多变量分析显示死亡/临终关怀出院、ICU停留至少1天或需要呼吸机至少1天的 odds 无差异。

要点

  • 新冠期前8周TBI就诊率下降18%,后8周上升16%,累计就诊率与新冠前期无差异。
  • 新冠期TBI患者受伤超过1天就诊比例更高(p=0.046),压疮率从1.0%升至2.1%(p=0.002)。
  • 多变量分析显示新冠期与新冠前期死亡/临终关怀出院、ICU停留至少1天或需要呼吸机至少1天的 odds 无差异。

核心结论

  • 新冠 pandemic 早期TBI就诊人数 initially 低于2017-2019年新冠前水平,随后就诊率上升,致2020年3月13日至7月2日与新冠前期TBI总就诊率相似。
  • 新冠队列与就诊时间延迟、压疮率升高和出院需监管的负面影响相关。
  • 未来 pandemic 应对政策必须考虑照护TBI患者所需资源。

研究设计与样本

  • 查询密歇根创伤质量改进计划(MTQIP)数据库,含密歇根州和明尼苏达州36家一级和二级创伤中心数据。
  • 依据头/颈部简明损伤定级(AIS)编码识别TBI患者,比较2017-2019年3月13日至7月2日(新冠前期)与2020年3月13日至7月2日(新冠期)。
  • 分析TBI发生率、患者特征、损伤严重程度和结局差异。

主要发现

  • 新冠期前8周(3月13日至5月7日)TBI就诊率较新冠前期下降18%,后8周(5月8日至7月2日)上升16%。
  • 新冠期与新冠前期累计TBI就诊率无差异。
  • 以头/颈部最大AIS评分和格拉斯哥昏迷量表评分的TBI严重程度在两组间相似。
  • 新冠期TBI患者受伤超过1天就诊比例更高(p=0.046)。
  • 新冠期压疮率从1.0%升至2.1%(p=0.002),出院状态分布改变(p=0.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The authors' objective was to investigate the impact of the global COVID-19 pandemic on hospital presentation and process of care for the treatment of traumatic brain injuries (TBIs). Improved understanding of these effects will inform sociopolitical and hospital policies in response to future pandemics. METHODS: The Michigan Trauma Quality Improvement Program (MTQIP) database, which contains data from 36 level I and II trauma centers in Michigan and Minnesota, was queried to identify patients who sustained TBI on the basis of head/neck Abbreviated Injury Scale (AIS) codes during the periods of March 13 through July 2 of 2017-2019 (pre-COVID-19 period) and March 13, 2020, through July 2, 2020 (COVID-19 period). Analyses were performed to detect differences in incidence, patient characteristics, injury severity, and outcomes. RESULTS: There was an 18% decrease in the rate of encounters with TBI in the first 8 weeks (March 13 through May 7), followed by a 16% increase during the last 8 weeks (May 8 through July 2), of our COVID-19 period compared with the pre-COVID-19 period. Cumulatively, there was no difference in the rates of encounters with TBI between the COVID-19 and pre-COVID-19 periods. Severity of TBI, as measured with maximum AIS score for the head/neck region and Glasgow Coma Scale score, was also similar between periods. During the COVID-19 period, a greater proportion of patients with TBI presented more than a day after sustaining their injuries (p = 0.046). COVID-19 was also associated with a doubling in the decubitus ulcer rate from 1.0% to 2.1% (p = 0.002) and change in the distribution of discharge status (p = 0.01). Multivariable analysis showed no differences in odds of death/hospice discharge, intensive care unit stay of at least a day, or need for a ventilator for at least a day between the COVID-19 and pre-COVID-19 periods. CONCLUSIONS: During the early months of the COVID-19 pandemic, the number of patients who presented with TBI was initially lower than in the years 2017-2019 prior to the pandemic. However, there was a subsequent increase in the rate of encounters with TBI, resulting in overall similar rates of TBI between March 13 through July 2 during the COVID-19 period and during the pre-COVID-19 period. The COVID-19 cohort was also associated with negative impacts on time to presentation, rate of decubitus ulcers, and discharge with supervision. Policies in response to future pandemics must consider the resources necessary to care for patients with TBI.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Johnson RA, Eaton A, Tignanelli CJ, et al. Changes in patterns of traumatic brain injury in the Michigan Trauma Quality Improvement Program database early in the COVID-19 pandemic. J Neurosurg. 2022. PMID: 35901671. doi:10.3171/2022.5.JNS22244

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。